Skip to content

PHARMACEUTICAL PRODUCT DEVELOPMENT INC

CIK 0001003124

← back to feed
Revenue (TTM)
$1.57B
+3.8% YoY Q3 Oct 2011
Net Income (TTM)
$156.4M
−22.4% YoY Q3 Oct 2011
EPS Diluted (TTM)
$1.36
−22.4% YoY Q3 Oct 2011
Gross Margin
—
Q3 Oct 2011
Operating Margin
14.8%
Q3 Oct 2011
Net Margin
10.0%
Q3 Oct 2011
Free Cash Flow (TTM)
$185.22M
Q3 Oct 2011
Cash
$416.75M
Q3 Oct 2011
Total Debt
—
Q3 Oct 2011
Shares Outstanding
113.69M sh
Q3 Oct 2011

Revenue & Net Income

EPS (Diluted)

Margins

Cash Flow

Revenue Growth (YoY)

Balance Sheet

Cash vs Debt

Recent filings